多层螺旋CT和MRI在浸润性宫颈癌术前分期中的应用

沈玉忠，和朝生

（1. 陕西省府谷县人民医院CT 室，陕西 榆林，719400；2.陕西省礼泉县人民医院放射科，陕西 咸阳，713200）

浏览次数：145次 下载次数：330次

摘要：

目的 探讨多层螺旋CT和MRI在浸润性宫颈癌术前分期中的应用价值。方法 以2010年2月至2016年2月我院收治 的36例宫颈癌患者为研究对象，对其影像学检查结果及病理诊断结果进行比较，判断多层螺旋CT和MRI的诊断准确率。 结果36例患者中，域期患者16例（44.44%），芋期患者13 例（36.11%），郁期患者7 例（19.44%）。MRI 诊断总符合率为 83.33%（30/36），明显高于多层螺旋CT 的61.11%（22/36），差异有统计学意义（P<0.05）。结论 MRI 对浸润性宫颈癌的辅助诊 断及术前分期准确率优于多层螺旋CT，具有较高的准确率，值得临床广泛应用。 

关键词：浸润性宫颈癌；术前分期；多层螺旋CT；MRI

中图分类号：R730.4文献标志码：A文章编号：2096-1413(2017)01-0125-02

The application of MSCT and MRI in preoperative staging of invasive cervical carcinoma
SHEN Yu-zhong 1, HE Zhao-sheng 2
(1. CT Room, Fugu County People s Hospital, Yulin 719400; 2. Department of Radiology, Liquan County People s Hospital, Xianyang 713200, China)

ABSTRACT: Objective To explore the application value of MSCT and MRI in preoperative staging of invasive cervical carcinoma. Methods Thirty-six cases of patients with cervical cancer in our hospital from February 2010 to February 2016 were selected as the objects, and the imaging examination results and pathological diagnosis results of all patients were compared to judge the diagnostic accuracy of MSCT and MRI. Results Among 36 cases, there were 16 cases (44.44%) of stageⅡ, 13 cases (36.11%) of stage Ⅲ, 7 cases (19.44%) of stage Ⅳ, the diagnostic coincidence rate of MRI was 83.33% (30/36), which was significantly higher than 61.11% (22/36) of MSCT, and the difference was statistically significant (P<0.05). Conclusion MRI is superior to MSCT in the diagnosis and preoperative staging of invasive cervical cancer, which has a high accuracy rate and is worthy of wide application.
KEYWORDS: invasive cervical cancer; preoperative staging; MSCT; MRI

参考文献：
[1] CHEN Y,WANG J,WANG J,et al.Aptamer functionalized cisplatin-albumin nanoparticles for targeted delivery to epidermal growth factor receptor positive cervical cancer[J].J Biomed Nanotechnol,2016,12 (4): 656-666.
[2] 李思妹,王雅棣,陈建平,等.宫颈癌螺旋断层调强放疗的外放边界研究[J].中华放射医学与防护杂志,2016,36(3):216-219.
[3] 孙冬梅.CT及MRI 在宫颈癌诊断中的临床价值分析[J].中国医学创新,2015,12(31):146-149.
[4] 郝建成,郝金钢.MRI 在宫颈癌诊断与分期中的应用价值[J].肿瘤学杂志,2014,20(8):673-676.
[5] HANAWA S,MITSUHASHI A,MATSUOKA A,et al.Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy -induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy foruterine cervical cancer: a phase II study [J].Am J Clin Oncol,2016,24(11):1-6.
[6] 刘红宇,生启芳,裘华敏,等.50例宫颈癌术前MRI诊断与分期[J]. 中国现代医生,2014,52(15):47-49.
[7] FLEMING S,COOPER RA,SWIFT SE,et al.Clinical impact of FDG PET-CT on the management of patients with locally advanced cervicalcarcinoma[J].Clin Radiol,2014,69(12):1235-1243.
[8] MAJCHRZAK E,CHOLEWI俳SKI W,GOLUSI俳SKI W,et al.Carcinoma of unknown primary in the head and neck: The evaluation of the effectiveness of 18F-FDG-PET/CT, own experience[J].Rep Pract Oncol Radiother,2015,20(5):393-397.
[9] YAMASHITA H,NIIBE Y,OKUMA K,et al.Treatment results for Stage Ib cervical cancer after stage subdivision by MRI evaluation[J].Eur J Gynaecol Oncol,2014,35(5):499-502.
[10] 李建生,陈志军,汤日杰,等.MRI动态增强扫描对宫颈癌的诊断价值研究[J].中国医药指南,2014,12(7):3-4.